Cristiano Ronaldo Invests $7.5 Million in Herbalife Health Tech Unit, Takes 10% Stake as Stock Surges

Portuguese football superstar Cristiano Ronaldo has made a major investment in health and wellness technology developed by Herbalife Ltd., the nutritional supplements and wellness firm he has partnered with for more than a decade. Ronaldo has invested $7.5 million (around £6.3m) to acquire a 10% equity stake in a Herbalife subsidiary that holds the Pro2col technology.

The deal marks a significant move for the global sports icon, who has been Herbalife’s global nutrition partner since 2013, and reflects his growing focus on health tech and personalised wellness. The investment announcement also coincided with Herbalife’s latest financial results, which showed solid sales growth for 2025.

What Ronaldo’s Investment Means for Pro2col and Herbalife

Herbalife said Ronaldo’s investment gives him a 10% ownership interest in HBL Pro2col Software, LLC, a subsidiary that owns and operates the Pro2col platform, Herbalife’s digital, personalised health and wellness system.

Pro2col is designed to help users build tailored wellness plans. It works by collecting individual health and lifestyle data and generating personalised recommendations, including nutrition and daily habits. At the heart of the technology is Pro2Score, a proprietary wellness scoring system that measures progress against key health indicators.

Ronaldo’s investment is more than just financial. Along with buying the stake, he has agreed to provide services and sponsorship rights to the Pro2col platform, reinforcing his commitment to the project’s long-term success.

Herbalife’s Chief Executive Officer, Stephan Gratziani, said Ronaldo’s decision to take an ownership stake represented a shared belief in the power of personalised nutrition, data and technology to improve health outcomes globally.

Timeline: From Partnership to Ownership

Ronaldo and Herbalife have worked closely together for over a decade. The footballer first became the company’s global nutrition partner back in 2013. Since then, the relationship has expanded beyond sponsorship, including the launch of co-branded products such as the Herbalife24® CR7 Drive sports drink.

Until now, Ronaldo’s role with Herbalife had focused on branding and promotion. The new investment in Pro2col marks his first publicly disclosed ownership interest in a company unit that drives digital health solutions.

Industry observers say this move reflects broader trends in the wellness and tech industries, where sports stars are increasingly investing in health tech firms that align with their personal brand and long-term interests.

Impact on Herbalife Stock and Financials

The news of Ronaldo’s investment came as Herbalife reported its fourth-quarter and full-year 2025 financial results, which exceeded guidance. The company reported a 6.3% increase in Q4 net sales compared to 2024 and delivered full-year sales growth as adjusted earnings beat expectations.

Herbalife’s stock reacted positively to the announcement. Shares climbed significantly in trading, reflecting renewed investor confidence following news of both strong financial performance and Ronaldo’s backing.

Analysts have noted that the combination of earnings growth and a celebrity investor could enhance Herbalife’s brand profile and broaden interest in its Pro2col platform as it rolls out in more markets.

What Comes Next for Pro2col and Ronaldo’s Role

Herbalife has begun a phased beta rollout of Pro2col, initially offering access to distributors and customers in the United States, Canada and Puerto Rico. The company plans to expand the platform to additional markets in Europe, the Middle East and Africa (EMEA) in 2026.

Ronaldo’s personal support and visibility are expected to help raise awareness of the platform internationally. He has spoken about embracing health, data and innovation as part of his investment rationale, describing it as a natural evolution of his long relationship with Herbalife.

For Herbalife, the investment underscores its strategy to become a more data-driven health and wellness company that combines technology with personalised nutrition guidance.